The company said that it now owns a 6% stake in Cencora, trimming it down from 10% it previously held. It sold Cencora shares worth $1.1 billion in August. Walgreens has sold about $265 million worth ...

Leerink analyst Michael Cherny raised the firm’s price target on Cencora (COR) to $301 from $287 and keeps an Outperform rating on the shares ...

Cencora, Inc. (COR) reported earnings for first quarter that decreased from last year but beat the Street estimates. The company's ...

Shares of Cencora Inc. COR shed 1.64% to $254.21 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.50% to 6,040.53 and ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money, has been ...

Building on the success during the COVID-19 pandemic, independent community pharmacies are taking steps to enhance their readiness for future public health emergencies. Ozempic has been approved ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Cencora (COR) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Cencora COR has outperformed the market over the past 10 years by 6.19% on an annualized basis producing an average annual return of 17.58%. Currently, Cencora has a market capitalization of $49. ...

Cencora, Inc. (NYSE:COR – Get Free Report)’s share price reached a new 52-week high on Monday after JPMorgan Chase & Co. raised their price target on the stock from $289.00 to $301.00.